Catinazzo Thomas 4
4 · Relay Therapeutics, Inc. · Filed Mar 31, 2025
Insider Transaction Report
Form 4
Catinazzo Thomas
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-03-27$2.84/sh−298$846→ 379,133 total - Sale
Common Stock
2025-03-27$2.84/sh−4,566$12,967→ 374,567 total
Footnotes (3)
- [F1]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on March 26, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F2]Includes 254,354 shares underlying RSUs.
- [F3]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.